J Otolaryngol Ophthalmol Shandong Univ ›› 2017, Vol. 31 ›› Issue (6): 16-20.doi: 10.6040/j.issn.1673-3770.1.2017.040

Previous Articles     Next Articles

Standardization of the diagnosis and treatment of anaplastic thyroid carcinoma.

SUN Bin, GUO Bomin, KANG Jie, DENG Xianzhao, WU Bo, FAN Youben   

  1. Shanghai Jiao Tong University Affiliated Sixth Peoples Hospital General Surgery, Shanghai Jiaotong University Thyroid Disease Diagnosis and Treatment Center, Shanghai 200233, China
  • Received:2017-10-10 Online:2017-12-16 Published:2017-12-16

PDF (PC)

1137

Abstract: Anaplastic thyroid carcinoma(ATC)is the most aggressive malignant thyroid carcinoma, with rapid metastasis and high mortality rates. In clinical settings, surgery, radiotherapy, chemotherapy, and targeted therapy have been applied for comprehensive treatment. Till date, there is no standardized effective treatment. Herein, we present the “standardization” of the diagnosis and treatment of ATC based on our own clinical experience.

Key words: Standardization, Anaplastic thyroid carcinoma, Treatment

CLC Number: 

  • R736.1
[1] Kebebew E, Greenspan FS, Clark OH, et al. Anaplastic thyroid carcinoma. Treatment outcome and prognostic factors[J]. Cancer, 2005,103(7):1330-1335.
[2] Wendler J, Kroiss M, Gast K, et al. Clinical presentation, treatment and outcome of anaplastic thyroid carcinoma: results of a multicenter study in germany[J]. Eur J Endocrinol, 2016, 175(6):521-529.
[3] Segerhammar I, Larsson C, Nilsson IL, et al. Anaplastic carcinoma of the thyroid gland: treatment and outcome over 13 years at one institution[J]. J Surg Oncol, 2012, 106(8):981-986.
[4] Smallridge RC, Ain KB, Asa SL, et al. American thyroid association guidelines for management of patients with anaplastic thyroid cancer[J]. Thyroid, 2012, 22(11):1104-1139.
[5] Haddad RI, Lydiatt WM, Ball DW, et al. Anaplastic thyroid carcinoma, version 2.2015[J]. J Natl Compr Canc Netw, 2015, 13(9):1140-1150.
[6] Zivaljevic V, Tausanovic K, Paunovic I, et al. Age as a prognostic factor in anaplastic thyroid cancer[J]. Int J Endocrinol, 2014: 240513.
[7] Akaishi J, Sugino K, Kitagawa W, et al. Prognostic factors and treatment outcomes of 100 cases of anaplastic thyroid carcinoma[J]. Thyroid, 2011, 21(11):1183-1189.
[8] Sugitani I, Miyauchi A, Sugino K, et al. Prognostic factors and treatment outcomes for anaplastic thyroid carcinoma: Atc research consortium of japan cohort study of 677 patients[J]. World J Surg, 2012, 36(6):1247-1254.
[9] Yoshida A, Matuzu K. Analysis of long-term survivors in anaplastic thyroid carcinoma[J]. Nihon Geka Gakkai Zasshi, 2012, 113(4):373-377.
[10] Sugitani I, Hasegawa Y, Sugasawa M, et al. Super-radical surgery for anaplastic thyroid carcinoma: a large cohort study using the anaplastic thyroid carcinoma research consortium of japan database[J]. Head Neck, 2014, 36(3):328-333.
[11] 张宗敏, 徐震纲, 唐平章, 等. 重新认识甲状腺未分化癌[J]. 中国医学科学院学报, 2006,28(3):322-324. ZHANG Zongmin, XU Zhengang, TANG Pingzhang, et al. A retrospective analysis of anaplastic thyroid carcinoma[J]. Act Acad Med Sin, 2006, 28(3):322-324.
[12] Pierie JP, Muzikansky A, Gaz RD, et al. The effect of surgery and radiotherapy on outcome of anaplastic thyroid carcinoma[J]. Ann Surg Oncol, 2002, 9(1):57-64.
[13] Sun C, Li Q, Hu Z, et al. Treatment and prognosis of anaplastic thyroid carcinoma: experience from a single institution in china[J]. PloS one, 2013, 8(11):80011.
[14] Sherman EJ, Lim SH, Ho AL, et al. Concurrent doxorubicin and radiotherapy for anaplastic thyroid cancer: a critical re-evaluation including uniform pathologic review[J]. Radiother Oncol, 2011, 101(3):425-430.
[15] 房居高. 强化手术技能和规范诊疗是提高甲状腺癌疗效的根本[J]. 山东大学耳鼻喉眼学报,2016, 30(2):1-4. FANG Jugao. Operation skill and standard diagnosis and treatment are the basics of improving the curative effect of thyroid carcinoma[J]. J Otolaryngol Ophthal Shandong Univ, 2016, 30(2):1-4.
[16] Zhou M, Chen Y, Adachi M, et al. Single agent nanoparticle for radiotherapy and radio-photothermal therapy in anaplastic thyroid cancer[J]. Biomaterials, 2015, 57:41-49.
[17] Bhatia A, Rao A, Ang KK, et al. Anaplastic thyroid cancer: clinical outcomes with conformal radiotherapy[J]. Head Neck, 2010, 32(7):829-836.
[18] Lowe NM, Loughran S, Slevin NJ, et al. Anaplastic thyroid cancer: the addition of systemic chemotherapy to radiotherapy led to an observed improvement in survival-a single centre experience and review of the literature[J]. Sci World J, 2014: 674583.
[19] Seto A, Sugitani I, Toda K, et al. Chemotherapy for anaplastic thyroid cancer using docetaxel and cisplatin: report of eight cases[J]. Surg Today, 2015, 45(2):221-226.
[20] Savvides P, Nagaiah G, Lavertu P, et al. Phase ii trial of sorafenib in patients with advanced anaplastic carcinoma of the thyroid[J]. Thyroid, 2013, 23(5):600-604.
[21] Wein RO, Weber RS. Anaplastic thyroid carcinoma: Palliation or treatment?[J]. Curr Opin Otolaryngol Head Neck Surg, 2011, 19(2):113-118.
[22] Pennell NA, Daniels GH, Haddad RI, et al. A phase ii study of gefitinib in patients with advanced thyroid cancer[J]. Thyroid, 2008, 18(3):317-323.
[1] ZHU Mingqiong, LI Zheng, LIU Ru, TIAN Tao, PENG Jingli, LYU Qianyi, TAN Huaxia. The application of AI screening system based on OCT/OCTA in the evaluation of the effect of anti VEGF treatment in patients with diabetes macular edema [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2026, 40(1): 68-73.
[2] LU Zhaoyang, ZHAI Zhaoxue, WANG Huikang, SHAO Liting, ZHANG Yu. COVID-19 treatment-induced diabetic ketoacidosis combined with rhino-orbital cerebral mucormycosis: a case report and literature review [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2026, 40(1): 90-94.
[3] LIU Yijie, LU Xiuzhen, WU Qiuxin. Research rogress of exosomes in the pathogenesis, diagnosis and treatment in ophthalmic diseases [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2026, 40(1): 135-141.
[4] LI Zan, LU Qi, SHEN Weidong, HOU Zhaohui, WU Nan. Clinical diagnosis and treatment features of 18 cases of necrotizing otitis externa [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(6): 17-22.
[5] LIU Yuzhu, CHEN Yao, YUAN Tiejun, LI Chunsen, LI Bo. Larynx fibrosarcoma: a case report and literature review [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(6): 133-137.
[6] GU Zhanxin, ZHAO Zhouyang, ZHANG Xiaobin, YANG Yimei, HUANG Lijin, HUANG Yan. Syndrome differentiation treatment and understanding of traditional Chinese medicine in carotid blowout syndrome [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(4): 100-107.
[7] SHI Jinlian, LI Jianxing, HUANG Yousheng, LIN Mingxuan, LIU Lingyun, LU Yongtian. Research status and progress in diagnosis and treatment of laryngeal inflammatory myofibroblastic tumor [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(4): 186-192.
[8] WU Wei, WANG Lei, CHEN Sheng, LI Lianyong, WANG Gang. Multidisciplinary research and advances in gastro-oesophageal reflux disease [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(6): 1-14.
[9] LIU Lianlian, LI Jinrang. Obstructive sleep apnea and laryngopharyngeal reflux [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(6): 15-22.
[10] ZHU Lang, LIU Zhiqi. Utilization of real-world data from mobile health applications in therapeutic interventions for allergic rhinitis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(4): 135-139.
[11] ZHOU Yuhong, DENG Yingping. Progress of corneal collagen cross-linking for the treatment of thin keratoconic corneas [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(1): 115-121.
[12] ZONG Chunlin, LU Jinbiao, YANG Yong, SU Zhongping, YU Bo. Application study of the MDT module combined with a flipped classroom in clinical teaching of pediatric OSA [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2023, 37(6): 139-144.
[13] ZHANG Xiaohan, WEI Li, YANG Kaili, CHEN Haiyan, LI Yansong, WANG Ping. Study on the change of OCTA and its correlation with visual acuity in patients with CSC before and after TCM syndrome differentiation and treatment [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2023, 37(5): 115-122.
[14] ZHAO Hui, HUANG Chao, CUI Wenxuan, SI Mingwei, YANG Mengyao, WANG Hong, ZHOU Fang. Retinal artery occlusion during treatment of primary vitreoretinal lymphoma:a case report and literature review [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2023, 37(5): 123-127.
[15] JIN Jing, LENG Hui. Progress in treatment of olfactory dysfunction following SARS-Cov-2 [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2023, 37(5): 162-174.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Website Copyright: Editorial Office of Journal of Otolaryngology and Ophthalmology of Shandong University
Address: No.27 Shanda South Road, Jinan, Shandong, China. Post code: 250100 Tel: +86-0531-88366912 Email: ebhxb@sdu.edu.cn Supported by Beijing Magtech Co.Ltd